ProCE Banner Activity

CE / CME

Video on Hot Topics in IBD

Multimedia
Hear expert insights on optimal management of inflammatory bowel disease, strategies for achieving deep remission, and the latest data on biologics and JAK inhibitors.

Physicians: maximum of 0.75 AMA PRA Category 1 CreditTM

Nurses: 0.75 Nursing contact hour

Released: November 13, 2020

Expiration: November 12, 2021

No longer available for credit.

Share

Faculty

Uma Mahadevan

Uma Mahadevan, MD

Professor of Medicine, Division of Gastroenterology
Director, Center for Colitis and Crohn’s Disease
University of California San Francisco Medical School
San Francisco, California

William Sandborn

William Sandborn, MD

Professor
Chief of Gastroenterology

Division of Gastroenterology
University of California San Diego
San Diego, California

Provided by

Provided by the American Gastroenterology Association.
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Takeda Pharm USA

Partners

IOIBD

ProCE Banner

Target Audience

Gastroenterologists, nurses, and other healthcare providers who care for patients with IBD.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Develop initial IBD treatment strategies with the goal to achieve early deep remission in patients with moderate to severe disease
  • Consider the latest outcomes data on non-TNF inhibitor biologics or JAK inhibitors when considering switch therapy for patients who do not achieve sustained remission with conventional or TNF inhibitor regimens
  • Explore evidence-based strategies for IBD treatment de-escalation that may include dose reduction or drug discontinuation once sustained remission has been achieved
  • Compare and contrast JAK inhibitor selectivity for specific JAK enzymes and how these distinctions may potentially relate to safety outcomes

Faculty Disclosure

Primary Author

Uma Mahadevan, MD

Professor of Medicine, Division of Gastroenterology
Director, Center for Colitis and Crohn’s Disease
University of California San Francisco Medical School
San Francisco, California

Uma Mahadevan, MD, has disclosed that she has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Takeda and funds for research support from Genentech and Pfizer.

William Sandborn, MD

Professor
Chief of Gastroenterology

Division of Gastroenterology
University of California San Diego
San Diego, California

William Sandborn, MD, has disclosed that he has received funds for research support from AbbVie, Amgen, Atlantic Healthcare Limited, Celgene/Receptos, Genentech, Gilead Sciences, Janssen, Lilly, Pfizer, Prometheus, and Takeda; that he has received consulting fees from AbbVie, Alimentiv, Allergan, Amgen, Arena, Avexegen, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen, Kyowa Kirin Pharmaceutical Research, Landos, Lilly, Oppilan, Otsuka, Pfizer, Progenity, Prometheus, Reistone, Ritter, Seres, Shire, Sienna, Sigmoid, Sterna Biologicals, Sublimity, Takeda, Theravance, Tigenix, Tillotts, UCB Pharma, Ventyx, Vimalan, and Vivelix; that he holds stock or stock options with BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan, Prometheus, Progenity, Ritter, Shoreline Biosciences, Ventyx, and Vimalan; and that his spouse has received consulting fees from Iveric and Oppilan; holds stock or stock options from Escalier Biosciences, Iveric, Oppilan, Progenity, Prometheus, Shoreline Biosciences, Ventyx, and Vimalan; and is employed by Prometheus.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Julie Skowronski, FNP-BC

Julie Skowronski, MSN, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation Statement

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The AGA Institute designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the American Gastroenterological Association. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 13, 2020, through November 12, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


Improve clinicians’ competence in navigating the most challenging clinical issues to help ensure successful IBD care.